menu ☰
menu ˟

Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges

30 May 2013

Generic drug manufacturer Ranbaxy has agreed to pay a fine of $500m (£330m; €385m) to settle US government charges of fraud at two of its Indian factories, which came to light eight years ago. The...

30 May 2013

Click here to view the full article which appeared in British Medical Journal (BMJ)